Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
40
LABD Quote, Financials, Valuation and Earnings
Last price:
$7.09
Seasonality move
:
6.89%
Day range:
$6.92 - $7.57
52-week range:
$4.78 - $11.41
Dividend yield:
4.2%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
24.1M
Avg. volume:
23.1M
1-year change:
-42.6%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingDirexion Daily S&P Biotech Bear 3X Shares has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Direxion Daily S&P Biotech Bear 3X Shares has an estimated downside of -- from its current price of $7.10.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $7.10.
Fair Value
-
According to the consensus of 0 analysts, Direxion Daily S&P Biotech Bear 3X Shares has -- downside to fair value with a price target of -- per share.
LABD vs. S&P 500
-
Over the past 5 trading days, Direxion Daily S&P Biotech Bear 3X Shares has overperformed the S&P 500 by 7.96% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Direxion Daily S&P Biotech Bear 3X Shares does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Direxion Daily S&P Biotech Bear 3X Shares has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Direxion Daily S&P Biotech Bear 3X Shares reported revenues of --.
Earnings Growth
-
Direxion Daily S&P Biotech Bear 3X Shares has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Direxion Daily S&P Biotech Bear 3X Shares reported earnings per share of --.
Enterprise value:
--
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-23 | 2023-12-23 | 2023-12-23 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-23 | 2021-12-23 | 2022-12-23 | 2023-12-23 | ||
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | -- | -- | -- | |
| Current Liabilities | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | -- | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-23 | 2023-12-23 | 2023-12-23 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
LABD
Sector
Market Cap
--
--
Price % of 52-Week High
62.23%
--
Dividend Yield
4.2%
--
Shareholder Yield
--
--
1-Year Price Total Return
-42.6%
--
Beta (5-Year)
-2.374
--
Dividend yield:
4.2%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$6.76
200-day SMA
Buy
Level
$6.90
Bollinger Bands (100)
Buy
Level
5.48 - 6.5
Chaikin Money Flow
Sell
Level
-73M
20-day SMA
Buy
Level
$6.16
Relative Strength Index (RSI14)
Buy
Level
61.92
ADX Line
Sell
Level
10.01
Williams %R
Neutral
Level
-28.4052
50-day SMA
Buy
Level
$6.01
MACD (12, 26)
Buy
Level
0.31
25-day Aroon Oscillator
Buy
Level
56
On Balance Volume
Sell
Level
-235.7M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (1)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Stock Forecast FAQ
In the current month, LABD has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The LABD average analyst price target in the past 3 months is --.
-
Where Will Direxion Daily S&P Biotech Bear 3X Shares Stock Be In 1 Year?
According to analysts, the consensus estimate is that Direxion Daily S&P Biotech Bear 3X Shares share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Direxion Daily S&P Biotech Bear 3X Shares?
Analysts are divided on their view about Direxion Daily S&P Biotech Bear 3X Shares share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Direxion Daily S&P Biotech Bear 3X Shares is a Sell and believe this share price will rise from its current level to --.
-
What Is Direxion Daily S&P Biotech Bear 3X Shares's Price Target?
The price target for Direxion Daily S&P Biotech Bear 3X Shares over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is LABD A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Direxion Daily S&P Biotech Bear 3X Shares is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of LABD?
You can purchase shares of Direxion Daily S&P Biotech Bear 3X Shares via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Direxion Daily S&P Biotech Bear 3X Shares shares.
-
What Is The Direxion Daily S&P Biotech Bear 3X Shares Share Price Today?
Direxion Daily S&P Biotech Bear 3X Shares was last trading at $7.09 per share. This represents the most recent stock quote for Direxion Daily S&P Biotech Bear 3X Shares. Yesterday, Direxion Daily S&P Biotech Bear 3X Shares closed at $7.10 per share.
-
How To Buy Direxion Daily S&P Biotech Bear 3X Shares Stock Online?
In order to purchase Direxion Daily S&P Biotech Bear 3X Shares stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
